American Consumer Pessimism Hits Record Lows Economists Question When Confidence Will Recover Endeavour EXK Delivers Q1 2026 Beat EPS 021 vs 013 Expected HP HPQ Delivers Q1 2026 Beat EPS 081 vs 077 Expected Malaysias Q1 GDP Growth Slows to 54 as Cost Pressures Mount JW Therapeutics CEO China Pharma Sector Unaffected by Beijings Tech Deal Scrutiny SK Hynix Surpasses 1 Trillion Valuation as AI Demand Drives South Korean Chip Stocks Higher Reddit Shares Decline Following Metas Launch of Forum App for Facebook Groups Technical Indicators Point to Bullish Bias in Intermediate Term DeepSeeks Emergence Unlikely to Derail US AI Leaders Analysts Suggest Bitcoin ETFs See 226 Billion in Outflows Over TwoWeek Period ACAD Q1 2026 Earnings EPS Misses Estimates as Biotech Faces Profitability Headwinds DHI Group Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 63 ALKS Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise CREG Q1 2026 Earnings Negative EPS of 003 Amid No Revenue Reported Stock Plunges 3286 BIO Q1 2026 Earnings EPS Falls Short of Estimates Shares Gain HAS Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Response Nicolet Bankshares Inc NIC Edges Higher Amid Steady Sector Performance Yext Inc YEXT Slips 22 as Stock Tests Key Support at 366 GCL Global Holdings Warrants GCLWW Surge 28 as Penny Stock Sees Renewed Activity HubSpot Holds Steady at 20083 Key Levels and Potential Scenarios for HUBS Inventiva IVA Edges Higher as Shares Hold Above Key Support Zone Golar LNG GLNG Holds Steady Near Support as Trading Volume Remains Modest HR Block HRB Crushes Q1 2026 Estimates EPS 602 Tops Views Trump Revealed as Palantir Stock Buyer and Social Media Promoter AARP Partners with North Carolina Law Enforcement to Combat Rising Cryptocurrency ATM Scams AI Infrastructure Rout Sends Nasdaq Lower on DeepSeek Developments Scope for Meaningful Rate Cuts Ahead Says Credit Suisses Neelkanth Mishra Government of Andhra Pradesh and foundit Partner to Boost Employment and Skill Development Enanta Pharmaceuticals ENTA Q1 2026 Earnings NarrowerThanExpected Loss Eases NearTerm Concerns Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes